A stack by mendtherapy

Gut lining and systemic inflammation

BPC-157 for the gut work it was originally studied for, with KPV for the inflammatory side. Both are peptides with no completed human trial, which is the main thing to know.

Proposed8 weeks2 compounds

mendtherapy wrote this as a plan rather than a record. There is no dose log behind it, and nothing here says anybody followed it.

The schedule

Each compound in Gut lining and systemic inflammation, with dose and schedule.
Compound	Dose	How often	Weeks
BPC-157Oral is the route the gut literature used. It is also the route with the least evidence that anything is absorbed.	500 mcg	Once daily	1–8
KPV	400 mcg	Once daily	1–8

Copy this to my tracker Sign in to like this

Read thisThis is one person’s plan, published by them. We did not write it, check it, or verify that they followed it — and one person doing something is not evidence that it works or that it is safe. Every compound above links to what the published research actually says.

Report this

This page is educational. It describes what published research reports, not what you should do. Peptides discussed here are largely not approved for human use, and nothing on Bioalmanac is medical advice.

1 comment

Written by readers, not by us. Nothing here is checked, and a confident reply is not evidence.

northlab
3 Sept 2026
Oral BPC-157 is the honest weak point here and the summary says so, which is more than most write-ups manage. The gut studies were rat studies with oral dosing, so the route matches the literature — what nobody has established is whether an oral dose reaches anything in a person.

Create an account to comment. Reading takes none.